関連する実験動画
Updated: Jan 7, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
869
適応型食料不安介入の管理困難な高血圧患者に対する実現可能性:SMARTパイロット研究
Deepak Palakshappa1,2,3, Selina Quinones1, Adrianna L Elashker4
1Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Population health management
|December 30, 2025
まとめ
このパイロット研究は、適応型食料不安介入が実現可能であることを示しています。コミュニティヘルスワーカー(CHW)のサービスや医療的に調整された食事(MTM)などのサポートを調整することで、管理困難な高血圧の患者の血圧が改善しました。
背景:
- 食料不安は多くの患者に影響を与えており、調整されたヘルスシステム介入が必要です。
- 既存の介入では、食料支援に対する多様な患者のニーズを満たせない可能性があります。
- 適応型戦略は、画一的なアプローチよりも効果的なサポートを提供する可能性があります。
結論:
- 適応型食料不安介入は、ヘルスシステムの設定内で実現可能です。
- 患者の反応に基づいて介入を調整することで、血圧管理などの健康アウトカムを改善できます。
- この適応型モデルは、食料不安や慢性疾患管理などの複雑な患者のニーズに対応する可能性を示しています。
関連する概念動画
Hypertension V: Nursing Management
332
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
332
Heart Failure VI: Adjunct Therapies
233
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
233
Hypertension IV: Drug Therapy and Lifestyle Modifications
564
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
564
Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437
Bioavailability Study Design: Healthy Subjects Versus Patients
130
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
130
Hypertension I: Introduction
659
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
659

